Conversely, the choice of interrupting therapy with statins may be due to the sudden worsening of the clinical profile, which in turn may cause the observed risk excesses. Although possible, it is unlikely that this affected our findings for at least 2 reasons. First, it is unclear why the ...
First, usual dissemination of clinical outcomes evidence alone results in slow uptake of therapies. In a prior analysis of commercially insured individuals with type 2 diabetes and atherosclerotic cardiovascular disease, only 24.7% were taking high-intensity statins, 53.1% were taking ACEIs or ARBs, ...
This conference was attended by official government representatives from all WHO and UNICEF member countries, making it the first global health conference of this broad-reaching scale.1 The conference resulted in the Declaration of AlmaAta, which called for the achievement of “Health ...
First, subject pools are limited by the vehicle and mission constraints; at any given time, there are 3–6 astronauts and cosmonauts living aboard the ISS. Until future vehicle capabilities are realized, human presence in space will be limited to very small sample size, with any studies ...
115 In fact, up to 80% of patients with a clinically isolated syndrome already have radiographic evidence of disease activity (T2 or fluid-attenuated inversion recovery lesions without gadolinium enhancement) predating the onset of the first clinical presentation.120-122 In the near future, a new...
This is the first study to qualitatively explore the role of a HP, although some surveys have been conducted concerning duties, hours and MDT working [6, 17,18,19]. Our main findings concur with a previous study in 1995 of HPs performing administrative, clinical, educational and supply ...
The hospital founded the first ‘Department of Critical Care Medicine’ in Korea in March 2013, which is an independent medical department for ICUs. The pharmacy in this study began a clinical service for 15 bed Medical ICU unit in February 17, 2009 by creating a team consisting of one ...
(U09.9), compared with the primary definition that was based on a set of 13 predefined post–acute sequelae of COVID-19; and (9) outcomes were defined based on the first occurrence of any individual sequela, compared with the primary definition that accounted for both the number of ...
17 We specified time-varying covariates on the first date of each follow-up period. Data were missing or unknown for race/ethnicity for 2.3% of patients, for educational level for 7.6% of patients, and for rural vs urban residence for 0.2% of patients. For race/ethnicity and educational ...
Proportion of Novel Therapeutics Approved by the US Food and Drug Administration (FDA) From 2001 Through 2010 Affected by Any Postmarket Safety Event as of February 2017 View LargeDownload The median time from approval to the first event was 4.2 years (interquartile range, 2.5-6.0 years). ...